$LQDA

JEFFS ROGER sold $400K of LQDA (indirect holdings)

JEFFS ROGER (Chief Executive Officer) sold 6,428 indirectly-held shares of Liquidia Corp (LQDA) at $62.18 ($0.40M total) on 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JEFFS ROGER
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

Traders may briefly reassess sentiment around insider behavior, but the disclosure does not include new operational, financial, or regulatory information.

02

Market read

A fresh Form 4 provides a new, dated insider sale, but it is typically not a standalone catalyst for repricing fundamentals.

03

What to watch

Indirect holdings and the post-sale share count (1,041,667) may matter more than the sale size; without context on prior plans, the signal is weak.

Relevance 3/10Novelty 5/10Timing: filed 2026-05-28, transaction dated 2026-05-27

Background

The filing is an SEC Form 4 insider transaction by Liquidia’s CEO, reported as an open-market sale with a stated 10b5-1 plan.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia CEO Jeffs Roger sold 6,428 shares in an open-market transaction for about $399,712, under a 10b5-1 plan.

Expected impact

Likely limited, short-lived impact unless paired with other negative company-specific news.

Evidence & confidence

Form 4 provides a new, time-stamped transaction and confirms a pre-arranged 10b5-1 plan, which typically reduces signaling risk versus discretionary sales.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect routine liquidity needs rather than bearish expectations.

Key entities

  • Liquidia Corp

    Company whose CEO insider sale is disclosed on SEC Form 4.

  • Jeffs Roger

    CEO and director who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LQDAHighAI 8/10

Why is Liquidia stock cratering today?

Liquidia Corporation's stock fell 48.3% to $36.55 after a court ruled it infringed two claims of United Therapeutics' patent, impacting its YUTREPIA drug. The company plans to remove a key indication and may face further restrictions. United Therapeutics' stock rose. The broader market gained slightly.